Hematology 101: Blood Disorders, Tests & Treatments Explained
Hematology is the medical specialty that studies blood and blood-forming organs, exploring how blood cells function, develop, and sometimes malfunction. In hematology, clinicians examine red cells, white cells, platelets, and the clotting system to understand a wide range of conditions. This page, Hematology 101, offers a clear overview of common blood disorders, how tests diagnose them, and the latest, practical treatment options with clear explanations. The field emphasizes how laboratory findings connect to patient presentations and care decisions. Diagnosing hematologic conditions relies on a broad set of tests performed in hematology labs. A complete blood count (CBC) with differential provides counts and features of red cells, white cells, and platelets. A peripheral blood smear helps specialists assess cell shape and maturation. Iron studies, ferritin, and vitamin B12/folate levels help evaluate anemia, while coagulation panels (PT/INR, aPTT) assess clotting function. Advanced tests such as flow cytometry, cytogenetics, and molecular assays identify specific disorders, and bone marrow biopsy can reveal marrow cellularity and lineage. Imaging and clinical history further support interpretation within hematology practice. Common blood disorders seen through hematology include anemia, thrombocytopenia and platelet function disorders, coagulation abnormalities, and malignant conditions such as leukemia, lymphoma, and myeloma. Each condition presents with distinctive test patterns, clinical features, and management considerations. Understanding how test results translate into a differential diagnosis is a core skill in hematology, guiding the selection of investigations and the path toward a formal diagnosis. Treatment in hematology draws on multiple strategies. In many conditions, supportive measures such as transfusions or growth-factor therapies help manage blood counts while longer-term plans are developed. Medications that affect clotting or immune function, alongside targeted therapies or monoclonal antibodies aimed at specific disease processes, form a key part of care. Cellular therapies, including stem cell transplantation and newer approaches like CAR-T therapy, play a role for certain disorders, depending on patient factors. The latest practical options emphasize careful monitoring, individualized planning, and collaboration among specialists to align tests, diagnoses, and treatment decisions.
